Perrigo Adds Planks To Brand Platform With GSK, Novartis International OTCs
This article was originally published in The Tan Sheet
Perrigo expects its acquisition of OTC brands from the GSK/Novartis JV will provide opportunities to grow in Europe. The firm, with cash flow to support additional acquisitions, adds more branded products two months after it entered OTC brand competition with the close of its Omega Pharma deal.
Register for our free email digests: